Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuation. [electronic resource]
Producer: 20090917Description: 481-92 p. digitalISSN:- 1755-3245
- Action Potentials
- Animals
- Atrial Fibrillation -- drug therapy
- Calcium Signaling -- drug effects
- Carbachol -- pharmacology
- Cardiovascular Agents -- pharmacology
- Cats
- Cholinergic Agonists -- pharmacology
- Cyclic AMP -- metabolism
- Dogs
- GTP-Binding Protein alpha Subunits, Gi-Go -- antagonists & inhibitors
- GTP-Binding Protein beta Subunits -- metabolism
- GTP-Binding Protein gamma Subunits -- metabolism
- Heart Atria -- drug effects
- Microscopy, Confocal
- Myocytes, Cardiac -- drug effects
- Parasympathectomy -- methods
- Peptides -- pharmacology
- Potassium -- metabolism
- Receptor, Muscarinic M2 -- metabolism
- Refractory Period, Electrophysiological
- Time Factors
- Vagus Nerve -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.